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Late Complications in Tetralogy of Fallot?*
Michael R. Zile, MD, David Gregg, MDSEE PAGES 1 AND 86C hildhood repair of tetralogy of Fallot (TOF) isone of the great successes of congenitalheart surgery, with now >90% of patients
surviving to adulthood (1). Late complications
including sudden death, atrial and ventricular ar-
rhythmias, and heart failure, however, persist. After
childhood repair, most patients with TOF are left
with pulmonary regurgitation. Initially, even severe
pulmonary regurgitation is well tolerated with usu-
ally a relatively asymptomatic period for 20 to 30
years, but then late complications arise (2). It is not
clear what changes mediate the onset of symptoms
and late decompensation. Most studies have shown
a link to residual pulmonary regurgitation with resul-
tant right ventricular enlargement, but what triggers
the development of symptoms, ventricular failure,
and poor outcomes has been unclear. Increasing evi-
dence suggests that extracellular matrix (ECM)
changes and ventricular ﬁbrosis may play an impor-
tant role mediating the decline and could be either a
potential target for intervention or a guide to the
ideal timing of targeting late pulmonary valve
replacement or other therapeutic interventions.
Using magnetic resonance imaging (MRI) late gad-
olinium enhancement (LGE) to quantify focal ﬁbrosis,
increased LGE has shown correlation with severity of
disease (3). LGE, however, does not show the extent
of diffuse extracellular changes in the myocardium
and likely underestimates ECM changes. Increasingly,
MRI T1 mapping has been used to calculate extracel-
lular volume (ECV) fraction in a variety of cardio-
vascular states including heart failure, arrhythmia,
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can be a useful marker of myocardial ﬁbrosis, and T1-
derived ECV has been correlated with worse prog-
nosis in heart failure and arrhythmia (4).In this issue of iJACC, 2 papers provide insight into
the possible mechanisms of late complications in TOF
and give insight into left and right ventricular inter-
action in biventricular dysfunction. Both papers look
at diffuse ventricular ﬁbrosis using MRI T1 mapping
to calculate ECV in repaired TOF and evaluate the
relationship to clinical status and hemodynamics.
Chen et al. (5) look at biventricular ﬁbrosis calculating
extracellular volume fraction in both the left and
right ventricles, whereas Broberg et al. (6) limit
themselves to an evaluation of the left ventricle,
interested in the importance of left- and right-sided
interdependence in TOF. We are intrigued to see
studies validating in particular right heart MRI-
derived ECV, as the thin-walled right ventricle may
present unique imaging challenges.
The populations studied by each group are quite
different, which may affect conclusions and ﬁndings.
Perhaps, most importantly, the cohort in the Broberg
et al. (6) study is a much older group (mean age 40
years) than the cohort of Chen et al. (5) (mean age 23
years) and the age at initial repair is also considerably
later. The Broberg et al. (6) cohort with delayed initial
surgical treatment is therefore more reﬂective of
historical care and the cohort of Chen et al. (5) is
closer to contemporary care, with early repair of TOF
now the standard of care.
Both studies demonstrate increased myocardial
ECV in TOF compared with control subjects. Chen
et al. (5) additionally found that right ventricular (RV)
and left ventricular (LV) ECV directly correlates with
each other and that LV ECV was a strong independent
predictor of arrhythmia. This seems to reinforce the
concept that LV dysfunction in TOF may arise from
RV and LV interdependence (7) and provides new
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12insight that ECM changes may be important in the
pathophysiology. Extending the observation that
pulmonary regurgitation with progressive RV dilation
is linked to complications in TOF (8), Chen et al. (5)
also found that patients with primary volume over-
load and the most severe pulmonary regurgitation
had increased RV ECV, whereas patients with less
regurgitation and residual pulmonary stenosis did not
have the same increase in RV ECV. This may mirror
the observation that some patients with TOF and mild
residual stenosis fare better with less RV dilation
and dysfunction, perhaps resulting in less ECV
expansion (9). Although Chen et al. (5) show a weak
negative correlation between RV outlet tract gradient
and RV ECV, the range of gradients shown are fairly
modest, and in repaired TOF, increased RV outlet
tract gradient is also associated with a smaller
regurgitant volume. We, therefore, urge caution,
concluding that severe RV hypertension either from
pulmonary stenosis or other abnormalities is not a
driver of increased ECV, and, in fact, studies of pul-
monary hypertension have shown a relationship to
increased ﬁbrosis by LGE (10), and animal models of
pulmonary hypertension have shown increased
ﬁbrosis, both histologically and using T1 mapping (11).
The ﬁndings of Chen et al. (5) would support a theory
that ongoing pulmonary regurgitation with ongoing
RV volume overload triggers increased biventricular
ﬁbrosis, which may mediate late complications.
Although the left ventricle is not directly volume
overloaded, left-sided dysfunction and ﬁbrosis appear
to correlate with hemodynamic changes from right-
sided overload and dysfunction. We do not know the
mechanism of biventricular interaction, but possible
mediators are mechanical linkage through the shared
septum, electrical mediation from dyssynchrony, and
indirect stimulation through right heart dysfunction
triggering deleterious neurohormonal activation. In
repaired tetralogy, LV injury may also be remote, with
the left ventricle prone to premature ﬁbrosis with
aging as a result of childhood surgical or pre-repair
loading injury that is unmasked with time.
Although each study used slightly different
thresholds for abnormal left-sided ECV and tech-
niques to measure ECV, the Broberg et al. (6) cohort
also had a signiﬁcantly greater percentage of patients
with “abnormal” LV ECV than the Chen et al. (5)cohort. This may reﬂect the age of the population
with more time to develop or may reﬂect distant
injury to the LV delayed age of repair and different
surgical care in older repairs. It is therefore difﬁcult to
know whether we will see as much LV ﬁbrosis with
current care. Correlating with late clinical complica-
tions, Broberg et al. (6) found a strong correlation
between ECV and age and age at repair and functional
status as well as increased ECV, wider QRS, and
increased markers of congestive heart failure. Fol-
lowed prospectively, increased ECV also predicted
worse clinical outcome, suggesting a possible future
prognostic role for ECV in TOF.
Together these papers show the intriguing role of
increased biventricular ﬁbrosis in repaired TOF as a
possible mediator and predictor of worse clinical
outcome. These ﬁndings likely have implications for
noncongenital heart failure where biventricular
dysfunction also predicts worse outcome than iso-
lated left heart failure, yet the role of the right
ventricle is often ignored. Although many questions
remain, this work introduces rich investigations into
myocardial ﬁbrosis to include the right side of the
heart and show the perhaps underappreciated inter-
dependence between the left and right heart. The
right heart is unique from the left and will likely
require unique therapy to preserve function, and
greater interest in understanding the process of RV
ECM changes is an important step. These 2 studies are
likely to stimulate future studies seeking to under-
stand the role of ﬁbrosis in RV pathology, not only by
imaging but also through serum biomarker studies.
Future studies in TOF may show evaluation of ECV
and ECM activity to be a prognostic marker, a guide to
timing of late pulmonary valve replacement, or
potentially new therapeutic targets. More broadly, we
hope that a greater understanding of RV ﬁbrosis and
its role in clinical outcomes in congenital heart dis-
ease can be extrapolated and enlighten us about the
role of the right ventricle in left-sided failure, pul-
monary hypertension, and arrhythmia.
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